A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma
Author(s) -
Chuanhui Peng,
Zhijun Zhang,
Jian Wu,
Zhen Lv,
Jie Tang,
Haiyang Xie,
Lin Zhou,
Shusen Zheng
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/832712
Subject(s) - hepatocellular carcinoma , loss of heterozygosity , metastasis , cancer research , liver transplantation , biology , medicine , suppressor , carcinoma , pathology , oncology , transplantation , gene , cancer , genetics , allele
It has been demonstrated that loss of heterozygosity (LOH) was frequently observed on chromosomes 8p22-p23 in hepatocellular carcinoma (HCC) and was associated with metastasis and prognosis of HCC. However, putative genes functioning on this chromosomal region remain unknown. In this study, we evaluated LOH status of four genes on 8p22-p23 (MCPH1, TUSC3, KIAA1456, and ZDHHC2). LOH on ZDHHC2 was associated with early metastatic recurrence of HCC following liver transplantation and was correlated with tumor size and portal vein tumor thrombi. Furthermore, our results indicate that ZDHHC2 expression was frequently decreased in HCC. Overexpression of ZDHHC2 could inhibit proliferation, migration, and invasion of HCC cell line Bel-7402 in vitro . These results suggest an important role for ZDHHC2 as a tumor suppressor in metastasis and recurrence of HCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom